GHK-Cu, explained.
Copper peptide. Research, safety questions, and treatment context.
The form
More than one catalog form
The routine
Topical care can fit into a skincare routine.
The evidence
Small human studies of topical products
Forms listed in a June 2025 catalog. Current availability and individual instructions need confirmation.
On this page
A linked source is not a clinical endorsement. How we handle review and corrections.
- Legal status
- Compoundable now
Topical and other non-injectable forms returned to the FDA's compounding list on May 14, 2026. Injectable GHK-Cu has no lawful route until an FDA review due by February 2027.
- At Goodmorrow
- Offered when we open
What it is
GHK-Cu is a tiny peptide, three amino acids bound to a copper ion. Your body makes it, and blood levels fall with age. It has been in skin care since the 1990s.
What the evidence shows
The best evidence is for skin. Lab and small clinical studies show it supports wound healing and collagen production, and cosmetic studies show modest improvement in fine lines and firmness.
Evidence for injecting it, or for regrowing hair, is much thinner: mostly lab data and enthusiasm.
How Goodmorrow handles it
We prescribe compounded topical GHK-Cu. It's often paired with microneedling, which helps it reach deeper layers of skin.
For patients losing weight quickly on a GLP-1, it's part of how we look after skin along the way. See GLP-1 Plus.
Before you take it
- Pre-mixed vials that combine copper peptide with BPC-157 and TB-500 raise stability questions. Pharmacists have flagged that copper can react with other peptides in solution, and there's no independent data showing those blends hold up.
Stacks that include it
- GLOW stack: ghk-cu, bpc-157 and tb-500 for skin and repair
- KLOW stack: glow plus kpv
- GLP-1 Plus: our program for what the medication doesn't fix on its own
Questions people ask
Can I get GHK-Cu injections in Dallas?
Not lawfully right now. Injectable GHK-Cu came off the FDA's restricted list in April 2026, but it isn't on the allowed list either. The FDA has scheduled a review before the end of February 2027.
Does GHK-Cu help hair grow?
There's lab data and plenty of enthusiasm, but little clinical evidence in people. We'd rather tell you that than sell you a bottle.
Sources
- Secondary sourceFDA Peptide Update 2026: Removal from the Do Not Compound List Frier Levitt, August 2026
- Secondary sourceThe US Peptide Status Index Peptide America
- Research publicationRegenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data International Journal of Molecular Sciences, 2018
Good days ahead.
Join the opening list for appointment updates.